ThursdayMay 10, 2012 5:10 pm

TherapeuticsMD (TXMD) Launches Third Prescription Prenatal Vitamin

VitaMedMD™ RediChew™ Rxchewable prenatal vitamin contains company’s patented folate developed to further reduce impact of folic acid-related deficiencies. TherapeuticsMD™ Inc., parent company of vitaMedMD® LLC, a specialty pharmaceutical company focused on therapies exclusively for women, today announced the recent launch of its third prescription prenatal vitamin, vitaMedMD™RediChew™ Rx. The launch trails the introduction of vitaMedMD™ One Rx earlier this month and vitaMedMD™ Plus Rx last month, products similar to RediChew Rxin that they all contain the same combination of folic acid and the company’s patented fourth-generation folate, Quatrefolic®. Quatrefolic gives all three of the prenatal vitamins the potential to further…

Continue Reading

ThursdayMay 10, 2012 2:23 pm

Pershing Gold Corp. (PGLC) Phase I Drilling Discovery at Relief Canyon Significantly Increases Overall Mineralization Profile

Pershing Gold, the up and coming, Nevada-focused (Pershing County) precious metals developer, which has already established a solid acreage position via their Relief Canyon, Red Rock, and North Battle Mountain properties, reported today that a new high-grade zone of gold mineralization was discovered at the Relief Canyon Mine. All of the mineralization observed by this round of drilling is within the pit area or is on PGLC subsidiary, Gold Acquisition Corp. (GAC), wholly-owned unpatented mining claims. Phase I of the company’s drilling program for 2012 (began last year) and already we have a new discovery. The best part is the…

Continue Reading

ThursdayMay 10, 2012 2:21 pm

International Stem Cell Corp. (ISCO) Announces New Stem Cell Manufacturing Technologies

International Stem Cell Corp., developer of therapeutic applications of human parthenogenetic stem cells (hpSCs) and cell-based research and cosmetic products, announced today that they have developed new technologies to commercialize the use of human parthenogenetic stem cells to treat human diseases. The methods announced are able to produce populations of stem cells, in addition to their therapeutically valuable derivatives, at a higher level of purity and at a cost that is several times lower than previously reported techniques. Specifically, the company’s research team has developed a new method of generating high-purity populations of neural stem cells from hpSC, and then…

Continue Reading

ThursdayMay 10, 2012 2:19 pm

EnerNOC e (ENOC) Awarded Seven-Year Contract with San Francisco PUC

EnerNOC Inc. is a leading provider of energy efficient solutions, for reducing electricity demand, for commercial, industrial and institutional energy users. Some of the company's world class energy management applications include DemandSMART, SupplySMART, EfficiencySMART and CarbonSMART. The company today announced that it has been selected as the 'commissioning authority' in a seven-year contract with the San Francisco Public Utilities Commission. Through this master services agreement, EnerNOC will work closely with building construction stakeholders to ensure that the City of San Francisco's new buildings operate not only to the owners' specifications but also in an energy efficient manner. The contrast lasts…

Continue Reading

ThursdayMay 10, 2012 10:32 am

Mitel (MITL) Introduces New Cloud Based Service as the Next Stage in the Evolution of UCaas

Yesterday at Interop® 2012, Mitel, a leading provider of Unified Communications and Collaboration software solutions, announced their new approach for deploying Unified Communications-as-a-Service, AnyWare Infrastructure-as-a-Service (IaaS). AnyWareIaaS spreads Mitel’s FreedomArchitecture to provide IT organizations with the option of hosting Mitel’s virtualized UCC software in a virtual private datacenter delivered by MitelNetSolutions, the service provider division of Mitel. "UCC is mission-critical for us, but we also don't want to use our limited data center resources on it if we don't have to," said Jamie Vandermeuse, director of Operations at M2 Logistics Inc. "We evaluated other cloud-based UCC services, but they don't…

Continue Reading

ThursdayMay 10, 2012 8:23 am

Keep Up With Your MBA Friend – Reference Book Review

There is a lot of knowledge that goes into the MBA programs at the top business schools in the United States. After all, it takes nearly 4 years to complete and there is a massive amount of studying that must be done to get that degree. What if I told you that you can get a pocket dictionary like encyclopedia of all the information in an MBA program all in one book?It's true, and I happen to have a copy of it. The name of the book is;"The Vest Pocket MBA," by Jae K. Shim Ph.D., Joel G Siegal Ph.D.,…

Continue Reading

WednesdayMay 09, 2012 3:59 pm

UNR Holdings, Inc. (UNRH) Completes 3 Phases of Marshal Rybalko Project in Moscow

UNR Holdings, a commercial and real estate development company operating primarily in Moscow and its surrounding suburban communities, today announced it has completed the construction of phases IV, V, and VIII of its Marshal Rybalko Project. The project is a multi-functional residential complex that includes residential living, underground parking, and social resources and business establishments, located in the North-West Administrative District of Moscow. Upon completion, the total gross area of all of the developmental phases of the project will be more than 2 million square feet. The company expects to complete construction of all eight phases of the Marshal Rybalko…

Continue Reading

WednesdayMay 09, 2012 3:52 pm

ImmunoCellular Therapeutics Ltd. (IMUC) Updates on Clinical Activity and Patient Enrollment for Study of Brain Cancer Vaccine Candidate

ImmunoCellular Therapeutics, a biotech company focused on the development of novel immune-based cancer therapies, today issued an update on clinical trial site activity and patient enrollment for its phase II clinical trial of ICT-107, the company's cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM), the most aggressive malignant primary brain tumor. The company reports that it has initiated the trial in 25 sites, and that it expects to enroll approximately 200 or more patients to treat 102 patients with HLA-A1/A2 immunological subtypes. There currently are 189 patients enrolled in the study, with final enrollment…

Continue Reading

WednesdayMay 09, 2012 1:42 pm

Complete Genomics (GNOM) Sequences Genomes in Type 2 Diabetes Genetic Study

Complete Genomics Inc. is whole human genome sequencing company that has developed and commercialized an innovative DNA sequencing service. The company's Complete Genomics Analysis Platform combines its proprietary human genome sequencing technology with advanced informatics and data management software. The company today announced that it has sequenced the genomes of 600 individuals from 20 Mexican-American from San Antonio, Texas. This is thought to be the largest whole genome sequencing family study conducted to date and the first such study of its kind in an Hispanic population. The study was funded by the National Institute of Diabetes and Digestive and Kidney…

Continue Reading

WednesdayMay 09, 2012 9:37 am

THQ Inc. (THQI) Video Chart for Wednesday, May 9, 2012

After hitting a 45 cent low last month, THQI made a strong move to hit 79 cents. A retracement has seen the stock go down to a support level around 65 cents, which may help the chart find a bottom. The support level must hold or the potential of falling back down to 45 cents is greatly increased. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered